IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q1 2019 Holdings

Filed 2019-05-15 | 2 holdings | $97.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aegerion Pharmaceuticals IncNOTE 2.000% 8/100767EAB8$86.8K$117,737,00088.7%
Kala Pharmaceuticals IncCOM483119103$11.0K1,333,33311.3%